Lindon, John C.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
John C. Lindon
VIAF ID: 2646276 (Personal)
Permalink: http://viaf.org/viaf/2646276
Preferred Forms
-
100 0 _
‡a
John C. Lindon
-
200 _ |
‡a
Lindon
‡b
John C.
-
100 1 _ ‡a Lindon, John C
-
100 1 _
‡a
Lindon, John C
-
100 1 _ ‡a Lindon, John C.
-
100 1 _
‡a
Lindon, John C.
-
100 1 _ ‡a Lindon, John C.
-
100 1 _ ‡a Lindon, John C.
-
100 1 _ ‡a Lindon, John C.
-
100 1 _ ‡a Lindon, John C.
-
100 1 _
‡a
Lindon, John C.
-
100 1 _ ‡a Lindon, John C.
-
100 1 _
‡a
Lindon, John C.
-
100 1 _
‡a
Lindon, John C.
4xx's: Alternate Name Forms (5)
5xx's: Related Names (2)
Works
| Title | Sources |
|---|---|
| The emergent role of metabolic phenotyping in dynamic patient stratification |
|
| Encyclopedia of spectroscopy and spectrometry |
|
| Evaluation of full-resolution J-resolved 1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification |
|
| Genetic algorithms for simultaneous variable and sample selection in metabonomics |
|
| A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection |
|
| The handbook of metabonomics and metabolomics |
|
| High-performance liquid chromatography/mass spectrometric and proton nuclear magnetic resonance spectroscopic studies of the transacylation and hydrolysis of the acyl glucuronides of a series of phenylacetic acids in buffer and human plasma |
|
| High-resolution 1H NMR spectroscopic investigation of a chick embryo model of neural tube development |
|
| Human metabolic profiles are stably controlled by genetic and environmental variation |
|
| Identification of human urinary biomarkers of cruciferous vegetable consumption by metabonomic profiling |
|
| Identifying unknown metabolites using NMR-based metabolic profiling techniques |
|
| The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies |
|
| Investigation of the metabolism of 14C/13C-practolol in rat using directly coupled radio-HPLC-NMR-MS |
|
| J-Resolved 1H NMR 1D-Projections for Large-Scale Metabolic Phenotyping Studies: Application to Blood Plasma Analysis. |
|
| Kinetic modelling of acyl glucuronide and glucoside reactivity and development of structure-property relationships |
|
| Mapping the biochemical trajectory of nephrotoxicity by pattern recognition of NMR urinanalysis |
|
| Mechanistic aspects and novel biomarkers of responder and non-responder phenotypes in galactosamine-induced hepatitis |
|
| A Metabolic Entropy Approach for Measurements of Systemic Metabolic Disruptions in Patho-Physiological States |
|
| Metabolic phenotyping in clinical and surgical environments |
|
| Metabolic phenotyping in personalized and public healthcare |
|
| Metabonomic investigations into the global biochemical sequelae of exposure to the pancreatic toxin 1-cyano-2-hydroxy-3-butene in the rat. |
|
| Metabonomics in toxicity assessment |
|
| Multiplatform serum metabolic phenotyping combined with pathway mapping to identify biochemical differences in smokers. |
|
| NMR and MS urinary metabolic phenotyping in kidney diseases is fit-for-purpose in the presence of a protease inhibitor |
|
| NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology |
|
| NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat. |
|
| NMR in pharmaceutical sciences |
|
| NMR spectroscopic studies on the in vitro acyl glucuronide migration kinetics of Ibuprofen ((+/-)-(R,S)-2-(4-isobutylphenyl) propanoic acid), its metabolites, and analogues |
|
| NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines |
|
| NMR spectroscopy using liquid crystal solvents, 1975: |
|
| Non-linear modeling of 1H NMR metabonomic data using kernel-based orthogonal projections to latent structures optimized by simulated annealing |
|
| Optimized Phenotypic Biomarker Discovery and Confounder Elimination via Covariate-Adjusted Projection to Latent Structures from Metabolic Spectroscopy Data |
|
| Panorganismal gut microbiome-host metabolic crosstalk |
|
| Pharmacometabonomic Characterization of Xenobiotic and Endogenous Metabolic Phenotypes That Account for Inter-individual Variation in Isoniazid-Induced Toxicological Response |
|
| Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism |
|
| Pharmacometabonomic Investigation of Dynamic Metabolic Phenotypes Associated with Variability in Response to Galactosamine Hepatotoxicity |
|
| Pharmacometabonomics as an effector for personalized medicine. |
|
| Precision High-Throughput Proton NMR Spectroscopy of Human Urine, Serum, and Plasma for Large-Scale Metabolic Phenotyping |
|
| Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach |
|
| Processing and modeling of nuclear magnetic resonance (NMR) metabolic profiles. |
|
| Proposed minimum reporting standards for chemical analysis |
|
| Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artefact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples |
|
| Quantitative Lipoprotein Subclass and Low Molecular Weight Metabolite Analysis in Human Serum and Plasma by 1H NMR Spectroscopy in a Multilaboratory Trial |
|
| Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery |
|
| Robust algorithms for automated chemical shift calibration of 1D 1H NMR spectra of blood serum |
|
| Robust data processing and normalization strategy for MALDI mass spectrometric imaging |
|
| Self-modeling curve resolution recovery of temporal metabolite signal modulation in NMR spectroscopic data sets: application to a life-long caloric restriction study in dogs |
|
| Seminal oligouridinosis: low uridine secretion as a biomarker for infertility in spinal neurotrauma |
|
| Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease |
|
| Species variation in the fecal metabolome gives insight into differential gastrointestinal function |
|
| Stability and Robustness of Human Metabolic Phenotypes in Response to Sequential Food Challenges |
|
| Statistical spectroscopic tools for biomarker discovery and systems medicine |
|
| Statistical total correlation spectroscopy editing of 1H NMR spectra of biofluids: application to drug metabolite profile identification and enhanced information recovery. |
|
| A statistically rigorous test for the identification of parent-fragment pairs in LC-MS datasets |
|
| Subset Optimization by Reference Matching (STORM): An Optimized Statistical Approach for Recovery of Metabolic Biomarker Structural Information from 1H NMR Spectra of Biofluids |
|
| Synthesis, transacylation kinetics and computational chemistry of a set of arylacetic acid 1beta-O-acyl glucuronides. |
|
| Systems biology: Metabonomics |
|
| Targeting the human genome-microbiome axis for drug discovery: inspirations from global systems biology and traditional Chinese medicine. |
|
| Temporal metabonomic modeling of l-arginine-induced exocrine pancreatitis |
|
| Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model |
|
| Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy. |
|
| Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity. |
|
| Topological analysis of metabolic networks integrating co-segregating transcriptomes and metabolomes in type 2 diabetic rat congenic series |
|
| Ultra performance liquid chromatography-mass spectrometry profiling of bile acid metabolites in biofluids: application to experimental toxicology studies. |
|
| Untargeted Metabolome Quantitative Trait Locus Mapping Associates Variation in Urine Glycerate to Mutant Glycerate Kinase |
|
| UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers |
|
| Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls |
|
| Urinary metabolites of 2-bromoethanamine identified by stable isotope labelling: evidence for carbamoylation and glutathione conjugation |
|
| The urinary proteome and metabonome differ from normal in adults with mitochondrial disease |
|
| Workflow for Integrated Processing of Multicohort Untargeted 1H NMR Metabolomics Data in Large-Scale Metabolic Epidemiology |
|
